Wenzhou Kangning Hospital Co Ltd
HKEX:2120
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
10.28
15.08
|
| Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Wenzhou Kangning Hospital Co Ltd
Wenzhou Kangning Hospital Co Ltd
Research & Development
Wenzhou Kangning Hospital Co Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Wenzhou Kangning Hospital Co Ltd
HKEX:2120
|
Research & Development
-¥34.4m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
N/A
|
|
|
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
Research & Development
-¥320.6m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
Hengkang Medical Group Co Ltd
SZSE:002219
|
Research & Development
-¥28.3m
|
CAGR 3-Years
-803%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
|
X
|
XiAn International Medical Investment Co Ltd
SZSE:000516
|
Research & Development
-¥6m
|
CAGR 3-Years
20%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
H
|
Huaxia Eye Hospital Group Co Ltd
SZSE:301267
|
Research & Development
-¥62.3m
|
CAGR 3-Years
-57%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Sanbo Hospital Management Group Ltd
SZSE:301293
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Wenzhou Kangning Hospital Co Ltd
Glance View
Wenzhou Kangning Hospital Co., Ltd. engages in the management of network of healthcare facilities, which focuses on the provision of psychiatric specialty care. The company is headquartered in Wenzhou, Zhejiang and currently employs 3,763 full-time employees. The company went IPO on 2015-11-19. The firm's main businesses include the provision of general medical services such as diagnosis and treatment, inpatient and outpatient services through the Company's own hospitals, and the sale of drugs. The firm is engaged in the operation and management of hospital facilities such as Wenzhou Kangning Hospital, Cangnan Kangning Hospital, Yueqing Kangning Hospital, geriatric hospitals and etc.
See Also
What is Wenzhou Kangning Hospital Co Ltd's Research & Development?
Research & Development
-34.4m
CNY
Based on the financial report for Jun 30, 2024, Wenzhou Kangning Hospital Co Ltd's Research & Development amounts to -34.4m CNY.
What is Wenzhou Kangning Hospital Co Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
-34%
Over the last year, the Research & Development growth was -6%. The average annual Research & Development growth rates for Wenzhou Kangning Hospital Co Ltd have been -4% over the past three years , -34% over the past five years .
You don't have any saved screeners yet
